Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

Stock Information for Spero Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Spero Therapeutics Inc.

UPDATE - Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024
Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update
Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024
Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy
Spero Therapeutics to Present at Upcoming September Investor Conferences

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.